RETA - 10

All Details

RETA - 10

RETA- 10 / 1 VIAL X 10MG VIAL.

Retatrutide is an investigational triple-agonist peptide (acting on GLP-1, GIP, and glucagon receptors) studied for weight loss, not muscle building. It is not authorized or approved for daily use in bodybuilding or weight management. For weight management in research studies, it is administered via subcutaneous injection once per week, often beginning with lower amounts and adjusting over time.

Usage Context and Considerations

While retatrutide may be used off-label by individuals for rapid fat reduction, particularly during "cutting" phases, it carries significant risks related to muscle retention:

Fat Loss and Muscle Mass: The rapid weight loss induced by intense appetite suppression may be accompanied by a reduction in muscle mass, which is often contrary to bodybuilding goals.

Preventive Strategies: To counteract potential muscle loss, intensive resistance training and high protein intake are generally advised for those undergoing significant calorie deficits.

Retatrutide starting dose

In clinical trials, people started retatrutide at different doses depending on their assigned treatment group.

The most common starting doses were:

2mg weekly: This was the most frequent starting point, particularly for people assigned to higher target doses (8mg or 12mg). Starting at 2mg gives your body more time to adjust before moving up to stronger doses, which helps minimise side effects.

4mg weekly: Some trial participants started at 4mg. This was used either as a fixed dose (staying at 4mg throughout) or as a faster escalation route to 8mg. Getting to a higher dose quicker leads to quicker weight loss, but may increase the risk of gastrointestinal side effects initially.